COVID-19 archive

Events, gatherings and activities

Consent form - vaccination of children and adolescents under 16 years

On this page you will find the consent form for vaccination of children and adolescents under the age of 16 against coronavirus.

Current recommendations for COVID-19

Stay home if you have newly arisen respiratory tract symptoms and feel unwell. You no longer need to be tested, and you do not need to stay home for four days with COVID-19. Contact a doctor if you need medical attention. Testing will be available for a while longer.

Universities, colleges, vocational schools and folk high schools

The article provides advice on infection prevention at universities, colleges, vocational colleges and folk high schools

Notification about risk of infection

You have been nearby someone who has confirmed coronavirus infection (COVID-19), but you no longer need to do anything specifically unless you have newly-arisen respiratory tract symptoms.

COVID-19 vaccination does not increase the risk of pregnancy complications

Women vaccinated against COVID-19 during pregnancy have no increased risk of pregnancy complications. These are the findings of a new international study of almost 160,000 births.

Low probability of long-term side effects after coronavirus vaccination

Over a year has passed since the first coronavirus vaccines became available. More than 11 million doses have been administered in Norway, and over 10 billion doses globally. This provides good insight and knowledge about side effects after coronavirus vaccination.

COVID-19: Post COVID-19 condition (new version)

In this rapid review, we summarise research on the proportion of patients who get long-term symptoms, which long-term symptoms occur after COVID-19, how long the symptoms persist and which patient groups that have the greatest risk of experiencing long-term symptoms.

Test criteria

Anyone above school age who has symptoms of COVID-19 should be tested, including people who are vaccinated.

When you are a close contact - archived

Here you will find information and advice to close contacts and those who are in quarantine.

When you are in isolation - archived

People with confirmed COVID-19 must go into isolation at home, at a healthcare institution or elsewhere.

When you shall take a coronavirus test - archive

Both self-testing with rapid antigen tests at home or testing at a test centre can be used. 

Infection control advice for travel during the COVID-19 pandemic - archived

Infection control advice for travel is updated continuously and can change quickly. Familiarise yourself with the advice that applies to travel in Norway and abroad, and for risk groups.

After you have been vaccinated or have had COVID-19

Vaccination and having had COVID-19 give good protection, but provides no guarantee against becoming infected (again) and infecting others.

Follow-up of close contacts and home isolation - archived

Advice to health personnel on follow-up of close contacts and home isolation.

Coronavirus vaccine from Novavax will be available in week 10

At the end of February, a small batch of Nuvaxovid, a coronavirus vaccine from Novavax will be available in Norway.

People with severe immune deficiency should take a booster dose (4th dose)

The Norwegian Institute of Public Health considers that more people with severely impaired immune systems should take a booster dose of coronavirus vaccine to ensure continued good protection. So far, only about 6,000 people in need of a booster dose have had one.

Organised sporting and leisure activities

Here you will find advice and guidance on organised sporting and leisure activities, such as music rehearsals, cultural activities, scouts, leisure clubs, homework help, etc.

COVID-19: Post COVID-19 condition

In this rapid review, we summarise research on the proportion of patients who get long-term symptoms, which long-term symptoms occur after COVID-19, how long the symptoms persist and which patient groups that have the greatest risk of experiencing long-term symptoms.

Offer of coronavirus immunisation for children and adolescents expanded

Following a recommendation from the Norwegian Institute of Public Health, the Government has decided to offer coronavirus vaccines to children aged 5–11 and a second dose to 12–15-year-olds.